Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2

BackgroundVaccination has proven the potential to control the COVID-19 pandemic worldwide. Although recent evidence suggests a poor humoral response against SARS-CoV-2 in vaccinated hematological disease (HD) patients, data on vaccination in these patients is limited with the comparison of mRNA-base...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Enikő Szabó, Szabolcs Modok, Benedek Rónaszéki, Anna Faragó, Nikolett Gémes, Lajos I. Nagy, László Hackler, Katalin Farkas, Patrícia Neuperger, József Á. Balog, Attila Balog, László G. Puskás, Gabor J. Szebeni
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2023-07-01
סדרה:	Frontiers in Medicine
נושאים:	hematology diseases SARS-CoV-2 vaccination BBIBP-CorV AZD1222 BNT162b2 COVID-19
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1176168/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!